Prospective study of Sofosbuvir/Ribavirin for HCV genotype 2 infected Japanese patients
Not Applicable
- Conditions
- Genotype 2 infected chronic liver diseases
- Registration Number
- JPRN-UMIN000019399
- Lead Sponsor
- Osaka City University and affiliated hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant women Decompensated cirrhosis Hepatocellular carcinoma Renal impairment (eGFR<30) Doctors judge as inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained viral response
- Secondary Outcome Measures
Name Time Method Suppression of hepatocarcinogenesis